Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Harvard Business School
Dow
Boehringer Ingelheim

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Carboprost tromethamine - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for carboprost tromethamine and what is the scope of patent protection?

Carboprost tromethamine is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd and Pharmacia And Upjohn, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for carboprost tromethamine. Two suppliers are listed for this compound.

Summary for carboprost tromethamine
Recent Clinical Trials for carboprost tromethamine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
C.R.Darnall Army Medical CenterN/A
American University of Beirut Medical CenterN/A

See all carboprost tromethamine clinical trials

Pharmacology for carboprost tromethamine
Medical Subject Heading (MeSH) Categories for carboprost tromethamine
Synonyms for carboprost tromethamine
(15S)-15-Methylprostaglandin F(sub 2alpha) tromethamine
(15S)-15-Methylprostaglandin F2alpha tromethamine
(5Z,9?,11?,15E,15S)-9,11,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid tris(hydroxymethyl)aminomethane salt
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(3S)-3-hydroxy-3-methyl-1-octenyl)cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
(Z)-7-[(1R,2S,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid 2-amino-2-(hydroxymethyl)propane-1,3-diol
15-Methyl PGF2 alpha
15-Methyl prostaglandin F2alpha
15-methylprostaglandin F2alpha-tromethamine
15(S)15-Methyl pgf2-alpha tromethamine salt
15(S)15-Methyl prostaglandin F2-alpha tromethamine
2-Amino-2-(hydroxymethyl)propane-1,3-diol (E)-7-((1s,3s,5r)-3,5-dihydroxy-2-((s,z)-3-hydroxy-3-methyloct-1-en-1-yl)cyclopentyl)hept- 5-enoate
2-amino-2-(hydroxymethyl)propane-1,3-diol; (E)-7-[(1S,3S,5R)-3,5-dihydroxy-2-[(Z,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyl-oct-1-enyl]cyclopentyl]hept-5-enoic acid
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid
551C692
58551-69-2
AC1NQXZK
AC1O5I8V
AKOS037435222
AN-10388
API0007240
C21H36O5
C25H47NO8
carboprost trometamol
Carboprost Trometanol
Carboprost tromethamine (USP)
Carboprost tromethamine [USAN:USP]
Carboprost tromethamine [USAN]
Carboprost Tromethanimine
CHEMBL1237105
D00682
Hemabate
Hemabate (TN)
I06-1950
J-507750
LS-125842
N916
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9-alpha,11-alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-15-methyl-, (5Z,9-alpha,11-alpha,13E,15S)-,compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prostin / 15M
Prostin/15
RP17766
SC-20243
SCHEMBL1649818
SCHEMBL433085
U 32921E
U-32,921E
U-32921
U-32921E
U32921
U4526F86FJ
UMMADZJLZAPZAW-XOWPVRJPSA-N
UNII-U4526F86FJ

US Patents and Regulatory Information for carboprost tromethamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn HEMABATE carboprost tromethamine INJECTABLE;INJECTION 017989-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd CARBOPROST TROMETHAMINE carboprost tromethamine INJECTABLE;INJECTION 211941-001 Jul 2, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.